Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2003-04-15
2011-10-04
Bristol, Lynn (Department: 1643)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
Reexamination Certificate
active
08030461
ABSTRACT:
Bispecific diabody libraries can be constructed from scFv libraries efficiently and without troublesome procedures by a single treatment, placing restriction enzyme sites appropriately for antigen-encoding regions.
REFERENCES:
patent: 7129330 (2006-10-01), Little et al.
patent: 2004/0219643 (2004-11-01), Winter et al.
patent: 2006/0159673 (2006-07-01), Kojima
patent: 2006/0269989 (2006-11-01), Miyazaki et al.
patent: 2 331 641 (1999-11-01), None
patent: 198 19 846 (1999-11-01), None
patent: 0 774 511 (1997-05-01), None
patent: 2001-523971 (2001-11-01), None
patent: WO 96/34892 (1996-11-01), None
patent: WO 98/50431 (1998-11-01), None
patent: WO 99/57150 (1999-11-01), None
patent: WO 00/44788 (2000-08-01), None
patent: WO 01/44282 (2001-06-01), None
patent: WO 01/70775 (2001-09-01), None
patent: WO 03/087163 (2003-10-01), None
Cekaite et al. Methods Mol Biol. 360:335-348 (2007).
McGuinness et al. (Nat. Biotech. 14:1149-1154 (1996)).
MacCallum et al. (J. Mol. Biol. (1996) 262:732-745).
Pascalis et al. The Journal of Immunology (2002) 169, 3076-3084.
Casset et al. (2003) BBRC 307, 198-205.
Vajdos et al. (2002) J. Mol. Biol. 320, 415-428.
Holm et al (2007) Mol. Immunol. 44: 1075-1084.
Chen et al. J. Mol. Bio. (1999) 293, 865-881.
Wu et al. J. Mol. Biol. (1999) 294, 151-162.
Smith-Gill et al. (J. Immunol. 139:4135-4144 (1987)).
Song et al. (Biochem Biophys Res Comm 268:390-394 (2000)).
Kumar et al. (J. Biol. Chem. 275:35129-35136 (2000)).
Clarkson et al. (Nature 352:624-628 (1991)).
Rousch et al., Br. J. Pharmacol., 125: 5-16 (1998).
New England Biolabs list of restriction enzymes (pp. 1-3, Dec. 30, 2009).
Desplancq et al. (Protein Engineering 7:1027-1033 (1994)).
Kim et al. (Protein Engineering, Design & Selection 20(9):425-432 (2007)).
Carter, “Bispecific human IgG by design,”J. Immunol. Methods, 248:7-15 (2001).
De Jonge et al., “Production and Characterization of Bispecific Single-Chain Antibody Fragments,”Mol. Immunol., 32:1405-1412 (1995).
Hoogenboom et al., “Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains,”Nucleic Acids Res., 19:4133-4137 (1991).
Hudson et al., “High avidity scFv multimers; diabodies and triabodies,”J. Immunol. Methods, 231:177-189 (1999).
Kipriyanov et al., “Effect of Domain Order on the Activity of Bacterially Produced Bispecific Single-chain Fv Antibodies,”J. Mol. Biol., 330:99-111 (2003).
Krebber et al., “Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system,”J. Immunol. Methods, 201:35-55 (1997).
Kurucz et al., “Retargeting of CTL by an Efficiently Refolded Bispecific Single-Chain Fv Dimer Produced in Bacteria,”J. Immunol., 154:4576-4582 (1995).
Little et al., “Of mice and men: hybridoma and recombinant antibodies,”Immunol. Today, 21:364-370 (2000).
Merchant et al., “An efficient route to human bispecific IgG,”Nat. Biotechnol., 16:677-681 (1998).
Peipp et al., “Bispecific antibodies targeting cancer cells,”Biochem. Soc. Trans., 30:507-511 (2002).
Plückthun et al., “New protein engineering approaches to multivalent and bispecific antibody fragments,”Immunotechnology, 3:83-105 (1997).
Ridgway et al., “‘Knobs-into-holes’ engineering of antibody CH3 domains for heavy chain heterodimerization,”Protein Eng., 9:617-621 (1996).
Shalaby et al., “Development of Humanized Bispecific Antibodies Reactive with Cytotoxic Lymphocytes and Tumor Cells Overexpressing theHER2Protooncogene,”J. Exp. Med., 175:217-225 (1992).
Skerra, “Use of the tetracycline promoter for the tightly regulated production of a murine antibody fragment inEscherichia coli,” Gene, 151:131-135 (1994).
Völkel et al., “Optimized linker sequences for the expression of monomeric and dimeric bispecific single-chain diabodies,”Protein Eng., 14:815-823 (2001).
Zuo et al., “An efficient route to the production of an IgG-like bispecific antibody,”Protein Eng., 13:361-367 (2000).
Supplemental IPER (Apr. 10, 2006).
Goldstein et al., “Cytolytic and Cytostatic Properties of an Anti-Human FcγRI (CD64)×Epidermal Growth Factor Bispecific Fusion Protein,”J. Immunol., 158:872-879 (1997).
McGuinness BT et al., “Phage diabody repertoires for selection of large number of bispecific antibody fragments”, Nature Biotechnology, vol. 14(9), pp. 1149-1154 (1996).
DeNardo D.G. et al., “Anti-HLA-DR/anti-DOTA diabody construction in modular gene design platform: bispecific antibodies for pretargeted radioimmunotherapy”, Cancer Biotherapy & Radiopharmaceuticals, vol. 16(6), pp. 525-535 (2001).
Andris-Widhopf J. et al., “Methods for the generation of chicken monoclonal antibody fragments by phage display”, Journal of Immunological Methods, vol. 242, pp. 159-181 (2000).
Turner D.J. et al., “Importance of the linker in expression of single-chain Fv antibody-fragments: optimization of peptide sequence using phage display technology”, Journal of Immunological Methods, vol. 205, pp. 43-54 (1997).
Tang Y. et al., “Selection of linkers for a catalytic single-chain antibody using phage display technology”, The Journal of Biological Chemistry, vol. 271(26), pp. 15682-15686 (1996).
Holliger P. et al., “‘Diabodies’, small bivalent and bispecific antibody fragments”, Proc. Natl. Acad. Sci. USA, vol. 90, pp. 6444-6448 (1993).
Cekaite et al., “Protein Arrays: A versatile toolbox for target identification and monitoring of patient immune responses”, Methods Mol. Biol., 360:335-348, 2007.
Kipriyanov and Little, “Generation of Recombinant Antibodies,”Molecular Biotechnology, 12:173-201 (1999).
Bristol Lynn
Chugai Seiyaku Kabushiki Kaisha
Fish & Richardson P.C.
LandOfFree
Methods for constructing scDb libraries does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for constructing scDb libraries, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for constructing scDb libraries will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4291724